TAE Life Sciences
Bringing new hope to patients with the most difficult to treat cancers.
![TAE-life-sciences-illustration-medical-biomarker Life-sciences medical biomarker at TAE Technologies (illustration)](https://tae.com/wp-content/uploads/TAE-life-sciences-illustration-medical-biomarker.png)
Shifting the paradigm.
TAE Life Sciences has exclusively licensed the patented particle accelerator technology developed by TAE for its pioneering work in fusion for a breakthrough biologically-guided radiation therapy based on Boron Neutron Capture Therapy (BNCT). TAE Life Sciences is developing comprehensive target drugs and a compact, cost-effective Alphabeam™ neutron source optimized to bring this promising treatment to patients and clinicians globally.
What is TAE Life Sciences?
TAE Life Sciences is a biotechnology company that was spun out by TAE Technologies in 2017 to develop and commercialize a breakthrough biologically targeted radiation treatment for the most difficult cancers. TAE Life Sciences’ Alphabeam™ neutron system is compact and practical for installation in a hospital setting.